-
Forward Look
Putting Data to WorkResearchers create breast cancer prediction models tailored for Asian Americans.
by Bradley Jones
-
Forward Look
Spotlight on Small Cell Lung CancerTreatments for small cell lung cancer have remained virtually the same for decades. Now, experts say that hope is on the horizon.
by Isobel Whitcomb
-
Rethinking Clinical Trials
Could changes spurred by safety concerns during the pandemic make clinical trials more accessible to patients?
by Charlotte Huff
-
Facts and Stats
Looking Closely at Lung CancerWhile there are many kinds of lung cancer, screening recommendations are standard across the board.
by Bradley Jones
-
Healthy Habits
An Alternative to MeatAre new plant-based meat alternatives a better way to satisfy burger cravings?
by Erin O’Donnell
-
Forward Look
New Treatment Approved for Lung CancerKRAS mutations were once thought to be resistant to drug therapy.
by Carisa Brewster
-
Forward Look
Predicting Colorectal Cancer RecurrenceLiquid biopsy tests can find tiny amounts of disease that remain after surgery and chemotherapy.
by Kris Conner
-
Forward Look
What’s Next? Fall 2021Oncolytic viruses to treat pediatric glioma.
by Natalie Slivinski
-
Forward Look
Cancer MisinformationBad advice shared online can have a negative effect, even if it's not followed.
by Erin O'Donnell
-
September 10: The Week in Cancer News
9/11 first responders' cancer survival compares favorably to the general population, and a study identifies different mutational signatures in lung cancers from never-smokers
by Marci A. Landsmann
Cancer Talk
Declining Breast Cancer Mortality in Younger Women
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin